Ingredient news
EFSA Publishes Novel-Food Opinion on Anaerobutyricum soehngenii CH106
By Nutranexa News |
EFSA's novel-food topic page lists its July 2026 scientific opinion on Anaerobutyricum soehngenii CH106.
What Was Reported
EFSA lists a scientific opinion on the safety of Anaerobutyricum soehngenii CH106 as a novel food pursuant to Regulation (EU) 2015/2283, published July 28, 2026. The item is one of several recent novel-food opinions shown on EFSA's topic page.
A novel-food opinion is specific to the organism, product identity, production method, proposed use, and dossier. It does not create a general approval for unrelated ingredients or methods.
Ingredient Buyer Context
When a PS buyer sees a novel-food reference in a customer questionnaire, record the exact route and intended use. Keep the supplier's source and process description consistent with the regulatory assessment and ask a qualified reviewer to confirm whether the reference is relevant.
The source concerns the named study, company, agency, or market development. It should not be expanded into a medical treatment claim, a universal ingredient result, or a guarantee about a supplier or finished product.
Nutranexa Takeaway
This EFSA item does not determine the market status of Nutranexa PS. It is a regulatory-monitoring brief.
For a product-specific discussion, provide the target market, application, source preference, PS grade, annual quantity, packaging, and required documents. Nutranexa can then discuss the relevant product and quality evidence without assuming facts that are not in the current controlled file.